Fermenta Biotech [FERMENTA] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Fermenta Biotech

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech wins in 10 metrics, Divi's Laboratories wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricFermenta BiotechDivi's LaboratoriesBetter
P/E Ratio (TTM)9.1367.57Fermenta Biotech
Price-to-Book Ratio2.6610.40Fermenta Biotech
Debt-to-Equity Ratio32.060.03Divi's Laboratories
PEG Ratio-0.022.55Fermenta Biotech
EV/EBITDA7.1249.66Fermenta Biotech
Profit Margin (TTM)19.81%23.89%Divi's Laboratories
Operating Margin (TTM)16.45%25.60%Divi's Laboratories
EBITDA Margin (TTM)16.45%25.60%Divi's Laboratories
Return on Equity21.44%14.64%Fermenta Biotech
Return on Assets (TTM)12.51%12.94%Divi's Laboratories
Free Cash Flow (TTM)$187.69M$2.15BDivi's Laboratories
Dividend Yield0.71%0.91%Divi's Laboratories
1-Year Return2.71%-5.14%Fermenta Biotech
Price-to-Sales Ratio (TTM)1.8116.13Fermenta Biotech
Enterprise Value$10.03B$1,522.01BDivi's Laboratories
EV/Revenue Ratio1.9015.77Fermenta Biotech
Gross Profit Margin (TTM)65.48%60.33%Fermenta Biotech
Revenue per Share (TTM)$181$363Divi's Laboratories
Earnings per Share (Diluted)$35.83$86.82Divi's Laboratories
Beta (Stock Volatility)-0.160.18Fermenta Biotech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fermenta Biotech vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Fermenta Biotech
Divi's Laboratories
Fermenta Biotech Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech-4.24%0.34%-8.40%-1.87%23.06%-17.75%
Divi's Laboratories4.77%2.26%-3.33%-15.42%10.79%-4.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech2.71%61.94%-8.27%70.06%70.06%70.06%
Divi's Laboratories-5.14%63.08%80.80%444.71%1,530.25%8,023.95%

News Based Sentiment: Fermenta Biotech vs Divi's Laboratories

Fermenta Biotech

News based Sentiment: POSITIVE

Fermenta Biotech’s Q3 FY24 results demonstrate significant revenue and profit growth, driven by its Vitamin D3 business. The company’s commitment to sustainability further enhances its long-term investment appeal, making this a noteworthy month for investors.

View Fermenta Biotech News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong quarterly results and is strategically diversifying its revenue base, but faces operational challenges and mixed analyst sentiment. The technical indicators also present a cautious outlook, creating a complex investment narrative with both opportunities and risks.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Fermenta Biotech vs Divi's Laboratories

MetricFERMENTADIVISLAB
Market Information
Market Cap i₹9.82B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i24,185455,187
90 Day Avg. Volume i29,849395,686
Last Close₹308.45₹6,104.50
52 Week Range₹219.00 - ₹449.00₹4,955.00 - ₹7,071.50
% from 52W High-31.30%-13.67%
All-Time High₹449.00 (Feb 10, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-31.30%-13.67%
Growth Metrics
Quarterly Revenue Growth0.74%0.14%
Quarterly Earnings Growth0.74%0.27%
Financial Health
Profit Margin (TTM) i0.20%0.24%
Operating Margin (TTM) i0.16%0.26%
Return on Equity (TTM) i0.21%0.15%
Debt to Equity (MRQ) i32.060.03
Cash & Liquidity
Book Value per Share (MRQ)₹123.23₹563.87
Cash per Share (MRQ)₹24.01₹132.86
Operating Cash Flow (TTM) i₹-59,490,000₹19.67B
Levered Free Cash Flow (TTM) i₹768.62M₹21.91B
Dividends
Last 12-Month Dividend Yield i0.71%0.91%
Last 12-Month Dividend i₹2.50₹60.00

Valuation & Enterprise Metrics Analysis: Fermenta Biotech vs Divi's Laboratories

MetricFERMENTADIVISLAB
Price Ratios
P/E Ratio (TTM) i9.1367.57
Forward P/E iN/A104.19
PEG Ratio i-0.022.55
Price to Sales (TTM) i1.8116.13
Price to Book (MRQ) i2.6610.40
Market Capitalization
Market Capitalization i₹9.82B₹1.61T
Enterprise Value i₹10.03B₹1.52T
Enterprise Value Metrics
Enterprise to Revenue i1.9015.77
Enterprise to EBITDA i7.1249.66
Risk & Other Metrics
Beta i-0.160.18
Book Value per Share (MRQ) i₹123.23₹563.87

Financial Statements Comparison: Fermenta Biotech vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FERMENTADIVISLAB
Revenue/Sales i₹1.36B₹24.10B
Cost of Goods Sold i₹470.43M₹9.56B
Gross Profit i₹892.20M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹224.21M₹6.17B
EBITDA i₹370.04M₹8.48B
Pre-Tax Income i₹280.87M₹7.33B
Income Tax i₹64.85M₹1.88B
Net Income (Profit) i₹216.02M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FERMENTADIVISLAB
Cash & Equivalents i₹282.40M₹4.15B
Total Current Assets i₹3.35B₹100.81B
Total Current Liabilities i₹2.12B₹14.52B
Long-Term Debt i₹194.91M₹20.00M
Total Shareholders Equity i₹3.59B₹149.69B
Retained Earnings i₹3.25B₹134.00B
Property, Plant & Equipment i₹2.16B₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FERMENTADIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFERMENTADIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i24,185455,187
Average Daily Volume (90 Day) i29,849395,686
Shares Outstanding i29.17M265.47M
Float Shares i8.54M120.77M
% Held by Insiders i0.70%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Fermenta Biotech vs Divi's Laboratories

MetricFERMENTADIVISLAB
Last 12-Month Dividend i₹2.50₹60.00
Last 12-Month Dividend Yield i0.71%0.91%
3-Year Avg Annual Dividend i₹0.83₹50.00
3-Year Avg Dividend Yield i0.71%0.70%
3-Year Total Dividends i₹2.50₹150.00
Ex-Dividend DateAug 06, 2025Jul 25, 2025